|
Volumn 37, Issue 6, 1995, Pages 1129-1145
|
Intratumoral chemotherapy
a a a a a |
Author keywords
Brain neoplasms; Chemotherapy; Controlled release; Drug delivery devices; Intratumoral injections; Polymers
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ALPHA1 INTERFERON;
BROXURIDINE;
CARMUSTINE;
DOXORUBICIN;
FLUOROURACIL;
GAMMA INTERFERON;
INTERLEUKIN 2;
METHOTREXATE;
MITOMYCIN C;
NIMUSTINE;
NITROSOUREA;
POLYMER;
RANIMUSTINE;
ANIMAL;
BRAIN TUMOR;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG IMPLANT;
GLIOMA;
HUMAN;
INFUSION PUMP;
INTRALESIONAL DRUG ADMINISTRATION;
PATHOLOGY;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC ACTIVITY;
BLOOD BRAIN BARRIER;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
DRUG DELIVERY SYSTEM;
GLIOBLASTOMA;
IMMUNOTHERAPY;
INTRATUMORAL DRUG ADMINISTRATION;
LYMPHOKINE ACTIVATED KILLER CELL;
PRIORITY JOURNAL;
SURGICAL TECHNIQUE;
SUSTAINED RELEASE PREPARATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG IMPLANTS;
GLIOMA;
HUMANS;
INFUSION PUMPS, IMPLANTABLE;
INJECTIONS, INTRALESIONAL;
TREATMENT OUTCOME;
|
EID: 0028844989
PISSN: 0148396X
EISSN: 15244040
Source Type: Journal
DOI: 10.1227/00006123-199512000-00013 Document Type: Review |
Times cited : (202)
|
References (0)
|